The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

34 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo.EBI
Anhui Medical University
Novel tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one: Design, synthesis, model and use as hMAO-B inhibitors.EBI
Anhui Medical University
Design and synthesis of celastrol derivatives as anticancer agents.EBI
Anhui Medical University
Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.EBI
Anhui Medical University
Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.EBI
Anhui Medical University
New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.EBI
Anhui Medical University
New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.EBI
Anhui Medical University
Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.EBI
Anhui Medical University
Design and synthesis of novel 5-phenyl-N-piperidine ethanone containing 4,5-dihydropyrazole derivatives as potential antitumor agents.EBI
Anhui Medical University
Discovery of a novel oral type Ⅰ CDK8 inhibitor against acute myeloid leukemia.EBI
Anhui Medical University
Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo.EBI
Anhui Medical University
Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease EBI
Anhui Medical University
Non-peptidyl non-covalent cathepsin C inhibitoEEr bearing a unique thiophene-substituted pyridine: Design, structure-activity relationship and anti-inflammatory activity in vivo.EBI
Anhui Medical University
Synthesis and biological evaluation of novel hybrids of phenylsulfonyl furoxan and phenstatin derivatives as potent anti-tumor agents.EBI
Anhui Medical University
Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.EBI
Anhui Medical University
Novel quinoline-based derivatives: A new class of PDE4B inhibitors for adjuvant-induced arthritis.EBI
Anhui Medical University
Discovery of the Novel 1EBI
Anhui Medical University
Design and Synthesis of a 2-Amino-pyridine Derivative as a Potent CDK8 Inhibitor for Anti-colorectal Cancer Therapy.EBI
Anhui Medical University
Discovery of Novel Pterostilbene-Based Derivatives as Potent and Orally Active NLRP3 Inflammasome Inhibitors with Inflammatory Activity for Colitis.EBI
Anhui Medical University
Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.EBI
Anhui Medical University
Discovery and EBI
Anhui Medical University
Discovery and development of novel pyrimidine and pyrazolo/thieno-fused pyrimidine derivatives as potent and orally active inducible nitric oxide synthase dimerization inhibitor with efficacy for arthritis.EBI
Anhui Medical University
Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents.EBI
Anhui Medical University
The structure-based optimization of δ-sultone-fused pyrazoles as selective BuChE inhibitors.EBI
Anhui Medical University
Discovery and SARs of 5-Chloro-EBI
Anhui Medical University
Discovery of δ-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies.EBI
Anhui Medical University
Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis.EBI
Anhui Medical University
Novel Pyrazolo[4,3- d]pyrimidine as Potent and Orally Active Inducible Nitric Oxide Synthase (iNOS) Dimerization Inhibitor with Efficacy in Rheumatoid Arthritis Mouse Model.EBI
Anhui Medical University
Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease.EBI
Anhui Medical University
Novel curcumin analogue hybrids: Synthesis and anticancer activity.EBI
Anhui Medical University
Free radical rearrangement synthesis and microbiological evaluation of novel 2-sulfoether-4-quinolone scaffolds as potential antibacterial agents.EBI
Anhui Medical University
Tricyclic pyrazolo[1,5-d][1,4]benzoxazepin-5(6H)-one scaffold derivatives: Synthesis and biological evaluation as selective BuChE inhibitors.EBI
Anhui Medical University
Novel amidrazone derivatives: Design, synthesis and activity evaluation.EBI
Anhui Medical University
Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitorsBDB
Incyte